{"id":656,"date":"2021-05-31T09:19:27","date_gmt":"2021-05-31T00:19:27","guid":{"rendered":"https:\/\/firm.or.jp\/en\/?page_id=656"},"modified":"2025-04-07T15:52:31","modified_gmt":"2025-04-07T06:52:31","slug":"home-and-abroad","status":"publish","type":"page","link":"https:\/\/firm.or.jp\/en\/home-and-abroad\/","title":{"rendered":"National and international regenerative medicine trends"},"content":{"rendered":"<section>\n<h2>Domestic trends<\/h2>\n<dl class=\"c-list--2\">\n<dt><a href=\"https:\/\/japan.kantei.go.jp\/\">Prime Minister&#8217;s Office of Japan<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.kantei.go.jp\/jp\/singi\/kenkouiryou\/en\/index.html\" target=\"_blank\" rel=\"noopener noreferrer\">Headquarters for Healthcare Policy<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.mhlw.go.jp\/stf\/english\/index.html\">Ministry of Health Labour and Welfare (MHLW)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.mhlw.go.jp\/english\/policy\/health-medical\/medical-care\/\">Medical Care: Regenerative Medicine<\/a><a href=\"https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/kenkou_iryou\/iryou\/saisei_iryou\/index.html\"><\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.meti.go.jp\/english\/index.html\">Ministry of Economy, Trade and Industry (METI)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.meti.go.jp\/english\/policy\/mono_info_service\/mono\/bio\/index.html\">BIO: Regenerative \/ Cellular medicine and gene therapies<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.mext.go.jp\/en\/index.htm\">Ministry of Education, Culture, Sports, Science and Technology Japan (MEXT)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.mext.go.jp\/en\/policy\/science_technology\/research_development\/title01\/detail01\/1373997.htm\">Promoting Research and Development in Life Sciences<\/a><a href=\"https:\/\/www.mext.go.jp\/b_menu\/shingi\/gijyutu\/gijyutu2\/044\/index.htm\"><\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.pmda.go.jp\/english\/index.html\">Pharmaceuticals and Medical Devices Agency (PMDA)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.pmda.go.jp\/english\/review-services\/reviews\/approved-information\/0001.html\">Information for Approved Products<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.amed.go.jp\/en\/\">Japan Agency for Medical Research and Development (AMED)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.amed.go.jp\/en\/program\/index03.html\">Project for Regenerative Medicine and Cell and Gene Therapies<\/a><a href=\"https:\/\/www.amed.go.jp\/program\/list\/13\/index.html\"><span><\/span><\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/en.jsrm.jp\/\">The Japanese Society for Regenerative Medicine (JSRM)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/en.jsrm.jp\/about-us\/journals\/\">REGENERATIVE THERAPY (journal)<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.keidanren.or.jp\/en\/\">Keidanren: Japan Business Federation<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.keidanren.or.jp\/en\/policy\/2023\/015_proposal.html\">Biotechnological Transformation (BX) Strategy<\/a><\/li>\n<\/ul>\n<\/dd>\n<\/dl>\n<\/section>\n<section>\n<h2>International trends<\/h2>\n<dl class=\"c-list--2\">\n<dt><a href=\"https:\/\/alliancerm.org\/\">Alliance for Regenerative Medicine (ARM)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/alliancerm.org\/cgt-development-japan\/\">Perspectives on Cell &amp; Gene Therapy Development, Manufacturing, and Commercialization In Japan<\/a><\/li>\n<li><a href=\"https:\/\/alliancerm.org\/manufacturing\/a-cell-2022\">A-Cell: A case study based approach to integrating QbD principles into cell-based therapy CMC programs<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/catapult.org.uk\/\">The Catapult Network<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/ct.catapult.org.uk\/resources\/clinical-trials-database\">Clinical trials database<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.fda.gov\/\">U.S. Food &amp; Drug Administration (FDA)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.fda.gov\/vaccines-blood-biologics\/cellular-gene-therapy-products\/approved-cellular-and-gene-therapy-products\">Approved Cellular and Gene Therapy Products<\/a><\/li>\n<\/ul>\n<\/dd>\n<dt><a href=\"https:\/\/www.ema.europa.eu\/en\/homepage\">European Medicines Agency (EMA)<\/a><\/dt>\n<dd>\n<ul>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/human-regulatory-overview\/advanced-therapy-medicinal-products-overview\">Advanced therapy medicinal products: Overview<\/a><\/li>\n<\/ul>\n<\/dd>\n<\/dl>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Domestic trends Prime Minister&#8217;s Office of Japan Headquarters for Healthcare Policy Ministry of Health L [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-656","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/656","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/comments?post=656"}],"version-history":[{"count":14,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/656\/revisions"}],"predecessor-version":[{"id":1625,"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/pages\/656\/revisions\/1625"}],"wp:attachment":[{"href":"https:\/\/firm.or.jp\/en\/wp-json\/wp\/v2\/media?parent=656"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}